• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The journal of sexual medicine >Factors Associated With Specific Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Sexual Dysfunctions in Breast Cancer Survivors: A Study of Patients and Their Partners
【24h】

Factors Associated With Specific Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Sexual Dysfunctions in Breast Cancer Survivors: A Study of Patients and Their Partners

机译：与精神障碍特定诊断和统计手册相关的因素，乳腺癌幸存者中的第四版性功能障碍：对患者及其合作伙伴的研究

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Abstract Background Many women develop sexual problems after breast cancer (BC) treatment. Little is known about BC survivors with a Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) sexual dysfunction and their partners, and the factors associated with their sexual functioning. Aim To evaluate (i) patient-related and clinical factors associated with (a) specific DSM-IV sexual dysfunctions and (b) level of sexual functioning and sexual distress as reported by BC survivors and (ii) the association between the sexual functioning of BC survivors and that of their partners. Methods We analyzed baseline data from a study of the efficacy of online cognitive-behavioral therapy for sexual dysfunction in BC survivors. Outcomes Women completed self-report questionnaires assessing sexual functioning, sexual distress, relationship intimacy, marital functioning, menopausal symptoms, body image, and psychological distress. Their partners completed questionnaires assessing sexual functioning. Results The study included 169 BC survivors and 67 partners. The most prevalent female sexual dysfunctions were hypoactive sexual desire disorder (HSDD; 83%), sexual arousal disorder (40%), and dyspareunia (33%). Endocrine therapy was associated with HSDD ( P ?= .003), and immunotherapy was associated with dyspareunia ( P ?= .009). Older age was associated with lower sexual distress ( P P ?= .004). An indication for erectile disorder was present in two thirds of partners. Lower overall partner sexual satisfaction was associated with lower overall BC survivor sexual functioning ( P ?= .001), lower female arousal ( P ?= .002), and lower female sexual satisfaction ( P ?= .001). Poorer male erectile function was related to higher female sexual pain ( P ?= .006). Partners of women who underwent breast reconstruction reported marginally significantly better orgasmic functioning ( P ?= .012) and overall sexual functioning ( P ?= .015) than partners of women who had undergone breast-conserving treatment. Clinical Implications BC survivors and their partners experience sexual problems after BC treatment. This suggests that not only the BC survivor but also her partner could benefit from sexual counseling. Strengths and Limitations This is the first study focusing on BC survivors with a DSM-IV sexual dysfunction and their partners. The results cannot necessarily be generalized to women experiencing milder sexual problems or who have no interest in receiving sexual counseling. Conclusion Endocrine therapy and immunotherapy are relevant risk factors for HSDD and dyspareunia in BC survivors. The sexual functioning of women and their partners is affected, underscoring the importance of involving both partners in sexual counseling after BC treatment. Hummel SB, Hahn DEE, van Lankveld JJDM, et?al. Factors Associated With Specific Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Sexual Dysfunctions in Breast Cancer Survivors: A Study of Patients and Their Partners. J?Sex Med 2017;14:1248–1259.
机译：抽象背景许多妇女在乳腺癌（BC）治疗以后发育性问题。关于BC幸存者的诊断和统计手册，第四版（DSM-IV）性功能障碍及其合作伙伴的诊断和统计手册，以及与其性能相关的因素有点令人着重。旨在评估（i）与（a）特异性Dsm-inv性功能障碍的患者相关和临床因素，（b）BC幸存者报告的性功能和性困难水平和（ii）性能之间的关系BC幸存者和他们的合作伙伴。方法从对BC幸存者中性功能障碍的疗效研究分析了基线数据。成果妇女完成自我报告问卷评估性功能，性困难，关系亲密，婚姻作用，更年期症状，身体形象和心理困扰。他们的合作伙伴完成了评估性功能的问卷。结果该研究包括169个BC幸存者和67个合作伙伴。最普遍的女性性功能困扰是低血压性欲障碍（HSDD; 83％），性唤醒障碍（40％）和疑难表达（33％）。内分泌治疗与HSDD相关（p？= .003），免疫疗法与疑难疗法有关（p？= .009）。年龄较大的年龄与性痛苦较低（P？= .004）。勃起障碍的指示存在于三分之二的合作伙伴中。较低的整体伴侣性满意与较低的整体BC幸存者性功能有关（P？= .001），低女性唤醒（P？= .002），较低的女性性满意度（P？= .001）。较差的男性勃起功能与更高的女性性疼痛有关（P？= .006）。接受乳房重建的妇女的合作伙伴报告了略微更好的高潮功能（P？= .012）和整体性功能（P？= .015）而不是经历哺乳治疗的女性的合作伙伴。临床影响BC幸存者及其合作伙伴在BC治疗后经历了性问题。这表明不仅是BC幸存者，而且她的伴侣也可以从性咨询中受益。优势和局限性这是重点关注BC幸存者与DSM-IV性功能障碍及其合作伙伴的研究。结果不一定是普遍化的妇女，遭受更平缓的性问题或者对接受性咨询没有兴趣的人。结论内分泌治疗和免疫疗法是BC幸存者中HSDD和DYSPAREUNIA的相关风险因素。妇女及其合作伙伴的性运作受到影响，强调了在BC治疗后涉及伴侣对性咨询的重要性。 Hummel Sb，Hahn Dee，Van Lankveld JJDM，et？al。乳腺癌幸存者的第四版性功能障碍与精神障碍特异性诊断和统计手册相关的因素：患者及其合作伙伴的研究。 J？性医学2017年; 14：1248-1259。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号